MAGEA9 and non-small cell lung carcinoma: Increased MAGE-A9 expression has also been associated with poor patient outcome and reduced survival in non-small cell lung cancer including squamous and adenocarcinoma, breast carcinoma and hepatocellular carcinoma [118,119,120].